Related Experiment Video
Updated: Jul 5, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Antibody markers for type 1 diabetes: the issues
1Endocrine Section (Medicine 11, Level D, South Block) of Southampton General Hospital, Southampton, UK.
Trends in Endocrinology and Metabolism: TEM
|March 1, 1990
Summary
Predicting diabetes mellitus is possible by detecting islet-cell autoantibodies before symptoms appear. High-titer islet cell antibodies show the most promise for clinical use in identifying individuals for preventive treatment.
Area of Science:
- Immunology
- Endocrinology
- Diabetes Research
Background:
- Autoantibodies targeting islet cells are potential early markers for diabetes mellitus.
- Predictive markers could enable targeted preventive interventions.
- Numerous markers have been investigated, but clinical utility remains limited.
Purpose of the Study:
- To evaluate the predictive value of islet-cell-specific autoantibodies for diabetes mellitus.
- To identify autoantibodies with sufficient specificity and sensitivity for clinical application.
Main Methods:
- Review of proposed islet-cell autoantibody markers.
- Assessment of specificity and sensitivity data for identified markers.
Main Results:
- Early detection of islet-cell autoantibodies may predict diabetes mellitus onset.
- Only high-titer islet cell antibodies have demonstrated adequate specificity and sensitivity.
Conclusions:
- High-titer islet cell antibodies are valuable predictive markers for diabetes mellitus.
- These markers have significant implications for identifying individuals eligible for preventive therapies.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...